Physician
Hematology
Dr. Nalini Janakiraman, MD
|
|
Give Review
Nalini Janakiraman practices Hematology. He studied medicine at Stanley Medical College SMC. He over the years received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Dr. Nalini Janakiraman is also a published doctor. He has 53 publication published. The most recent publication is: Nonselective inhibition of proliferation of transformed and nontransformed cells by the anticancer agent curcumin (diferuloylmethane). He accepts all Medicare patients.
Publications
- Blastic plasmacytoid dendritic cell neoplasm.
- Progression of double-hit lymphoma in the midst of R-hyper CVAD.
- Crack tip fracture toughness of base glasses for dental restoration glass-ceramics using crack opening displacements.
- Frequent expression of C4d in hepatic graft-versus-host disease: potential clue for diagnosis and distinguishing acute and chronic form.
- Single fraction spine radiosurgery for myeloma epidural spinal cord compression.
- Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant.
- Outcomes after auto-SCT in African Americans with multiple myeloma.
- Early relapses do not impact survival after autologous stem cell transplantation in African Americans with multiple myeloma.
- Phase II trial of idiotype vaccination in previously treated patients with indolent non-Hodgkin's lymphoma resulting in durable clinical responses.
- Hematologic malignancies with primary retroperitoneal presentation: clinicopathologic study of 32 cases.
- Unusual presentations of hematologic malignancies: CASE 2. Precursor B-cell lymphoblastic lymphoma presenting as spinal cord compression.
- In vitro analysis of the antileukemic effect of tumor necrosis factor-alpha gene therapy with myeloid progenitor cells: the role of dendritic cells.
- Curcumin (diferuloyl-methane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells.
- Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery.
- Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes.
- Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production.
- Therapy-related myelodysplastic syndrome (t-MDS) in a patient with anaplastic astrocytoma: successful treatment with allogeneic bone marrow transplant.
- IL-12 gene therapy of leukemia with hematopoietic progenitor cells without the toxicity of systemic IL-12 treatment.
- Interleukin-12 (IL-12) gene therapy of leukemia: immune and anti-leukemic effects of IL-12-transduced hematopoietic progenitor cells.
- Upper airway disease.
- Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging.
- Enhanced assessment of allogeneic bone marrow transplant engraftment using automated fluorescent-based typing.
- Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20(+) B-cell non-Hodgkin's lymphoma.
- Radioimmunotherapy of relapsed non-Hodgkin's lymphoma with zevalin, a 90Y-labeled anti-CD20 monoclonal antibody.
- Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin''s lymphoma.
- TNF-alpha gene therapy with myeloid progenitor cells lacks the toxicities of systemic TNF-alpha therapy.
- Nonselective inhibition of proliferation of transformed and nontransformed cells by the anticancer agent curcumin (diferuloylmethane).
- Antileukemic activity of TNF-alpha gene therapy with myeloid progenitor cells against minimal leukemia.
- Aspergillus fungal mass detected by transesophageal echocardiography.
- Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells.
- Transplantation in patients with multiple myeloma: a multicenter comparative analysis of peripheral blood stem cell and allogeneic transplant.
- IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma.
- Curcumin, a compound with anti-inflammatory and anti-oxidant properties, down-regulates chemokine expression in bone marrow stromal cells.
- IL-4 upregulates IL-1-induced chemokine gene expression in bone marrow stromal cells by enhancing NF-kB activation.
- Computed tomography in diagnosing retropharyngeal abscess in children.
- Transforming growth factor beta-1 (TGF-beta 1) potentiates IL1 alpha-induced IL6 mRNA and cytokine protein production in a human astrocytoma cell line.
- Superinfection with multiple organisms in children with measles.
- Induction of chemokine mRNA in bone marrow stromal cells: modulation by TGF-beta 1 and IL-4.
- Chemokine gene expression in bone marrow stromal cells: downregulation with sodium salicylate.
- Gallium 67 citrate scintigraphy in pyomyositis.
- Smoldering acute granulocytic leukemia. Observations on its natural history and morphologic characteristics.
- Pulmonary edema and coma from perchloroethylene.
- Chromosomal abnormality associated with congenital macroglossia and other abnormalities.
- Hyponatremia and central nervous system disease.
- Malignant somatostatinoma presenting with diabetic ketoacidosis.
- Primary fibrinolysis in acute monocytic leukemia.
- Osteomyelosclerosis with granulocytic sarcoma of chest wall. Morphological, ultrastructural, immunologic, and cytogenetic study.
- Assessment of methylprednisolone purging efficacy on Daudi burkitt lymphoma cells from normal bone marrow.
- Peripheral blood stem cell transplantation as an alternative to bone marrow transplantation: an overview.
- Pulmonary edema due to tetrachloroethylene.
- Hemolysis during BAL chelation therapy for high blood lead levels in two G6PD deficient children.
- Vitamin D poisoning: from ingestion of concentrated vitamin D used to fortify milk.
Schools
Madras Medical College Tamil Nadu Dr Mgr Medical University
Govt Stanley Hospital
Henry Ford Hospital
Procedures Preformed
- Bone Marrow Transplant
- HPC Transplantation (Stem Cell Transplant)
- Stem Cell Transplant
Doctors Specialties
- Hematology
Accepted Insurances
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Care Network PCP Focus Network
- Group Employees PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- First Health (Coventry Health Care) PPO
- Health Alliance
- Preferred PPO
- Choice Care PPO
- Medicare MCR
- Molina
- MultiPlan PPO
- PHCS Network PPO
- Priority PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
Henry Ford Hospital - Wayne State University -
Stanley Medical College SMC
Hospital
-
Henry Ford Hospital
Drug Facts
| NPI NUMBER | 1730257270 | |
| NPPES Provider LastName | JANAKIRAMAN | |
| NPPES Provider FirstName | NALINI | |
| NPPES Provider ZIPCode | 48202 | |
| NPPES Provider State | MI | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 321.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 18.0 | |
| Percent Opioid Claims | 5.61 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1730257270 |
| Last Name Of The Provider | JANAKIRAMAN |
| First Name Of The Provider | NALINI |
| View All |
Similar Doctors
|
Dr. Lawrence G. Lum, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Judith C. Andersen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leilei Chen, MD |
|
Dr. Shatha Y. Farhan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Edward M. Peres, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lois J. Ayash, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Richard M. Zuniga, MD |
|
|
Dr. Mihaela A. Vatca, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yaser Alkhatib, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wederson M. Claudino, MD |
|
|
George Yaghmour |